Sangamo Therapeutics (SGMO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Sangamo Therapeutics Revenue Highlights

Latest Revenue (Y)

$176.23M

Latest Revenue (Q)

$356.00K

Main Segment (Y)

License

Sangamo Therapeutics Revenue by Period

Sangamo Therapeutics Revenue by Year

Date	Revenue	Change
2023-12-31	$176.23M	58.34%
2022-12-31	$111.30M	0.54%
2021-12-31	$110.70M	-6.34%
2020-12-31	$118.19M	15.39%
2019-12-31	$102.43M	21.29%
2018-12-31	$84.45M	130.95%
2017-12-31	$36.57M	88.60%
2016-12-31	$19.39M	-50.96%
2015-12-31	$39.54M	-13.80%
2014-12-31	$45.87M	90.07%
2013-12-31	$24.13M	11.44%
2012-12-31	$21.66M	109.86%
2011-12-31	$10.32M	-50.40%
2010-12-31	$20.80M	-6.23%
2009-12-31	$22.19M	37.08%
2008-12-31	$16.19M	77.91%
2007-12-31	$9.10M	15.38%
2006-12-31	$7.88M	217.43%
2005-12-31	$2.48M	88.90%
2004-12-31	$1.31M	-49.01%
2003-12-31	$2.58M	-40.62%
2002-12-31	$4.34M	-11.10%
2001-12-31	$4.88M	42.30%
2000-12-31	$3.43M	56.05%
1999-12-31	$2.20M	7.95%
1998-12-31	$2.04M	76.91%
1997-12-31	$1.15M	82.28%
1996-12-31	$632.00K	-

Sangamo Therapeutics generated $176.23M in revenue during NA 2023, up 58.34% compared to the previous quarter, and up 208.68% compared to the same period a year ago.

Sangamo Therapeutics Revenue by Quarter

Date	Revenue	Change
2024-06-30	$356.00K	-25.99%
2024-03-31	$481.00K	-76.44%
2023-12-31	$2.04M	-78.27%
2023-09-30	$9.40M	37.50%
2023-06-30	$6.83M	-95.67%
2023-03-31	$157.96M	480.08%
2022-12-31	$27.23M	2.91%
2022-09-30	$26.46M	-9.93%
2022-06-30	$29.38M	4.06%
2022-03-31	$28.23M	0.88%
2021-12-31	$27.99M	-2.02%
2021-09-30	$28.56M	2.48%
2021-06-30	$27.87M	6.06%
2021-03-31	$26.28M	1.86%
2020-12-31	$25.80M	-55.33%
2020-09-30	$57.76M	168.00%
2020-06-30	$21.55M	64.83%
2020-03-31	$13.08M	-76.16%
2019-12-31	$54.85M	149.80%
2019-09-30	$21.96M	25.13%
2019-06-30	$17.55M	117.42%
2019-03-31	$8.07M	-69.93%
2018-12-31	$26.84M	13.90%
2018-09-30	$23.56M	10.02%
2018-06-30	$21.42M	69.47%
2018-03-31	$12.64M	-3.36%
2017-12-31	$13.08M	10.71%
2017-09-30	$11.81M	43.12%
2017-06-30	$8.25M	140.96%
2017-03-31	$3.42M	-61.61%
2016-12-31	$8.92M	216.05%
2016-09-30	$2.82M	-23.74%
2016-06-30	$3.70M	-6.09%
2016-03-31	$3.94M	-56.78%
2015-12-31	$9.12M	6.44%
2015-09-30	$8.57M	2.52%
2015-06-30	$8.36M	-38.05%
2015-03-31	$13.49M	-9.77%
2014-12-31	$14.95M	20.42%
2014-09-30	$12.42M	19.57%
2014-06-30	$10.38M	27.96%
2014-03-31	$8.12M	18.15%
2013-12-31	$6.87M	20.36%
2013-09-30	$5.71M	-17.70%
2013-06-30	$6.93M	49.99%
2013-03-31	$4.62M	-48.24%
2012-12-31	$8.93M	82.03%
2012-09-30	$4.91M	7.28%
2012-06-30	$4.57M	41.09%
2012-03-31	$3.24M	-31.72%
2011-12-31	$4.75M	155.68%
2011-09-30	$1.86M	22.66%
2011-06-30	$1.51M	-31.18%
2011-03-31	$2.20M	-53.08%
2010-12-31	$4.69M	59.33%
2010-09-30	$2.94M	-54.90%
2010-06-30	$6.53M	-1.85%
2010-03-31	$6.65M	-35.08%
2009-12-31	$10.24M	152.06%
2009-09-30	$4.06M	-14.03%
2009-06-30	$4.73M	49.70%
2009-03-31	$3.16M	-53.80%
2008-12-31	$6.83M	82.48%
2008-09-30	$3.75M	31.77%
2008-06-30	$2.84M	2.78%
2008-03-31	$2.77M	-0.07%
2007-12-31	$2.77M	-

Sangamo Therapeutics generated $356.00K in revenue during Q2 2024, up -25.99% compared to the previous quarter, and up 0.23% compared to the same period a year ago.

Sangamo Therapeutics Revenue Breakdown

Sangamo Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Service	$2.68M	-	-	-	-
License	$132.16M	$37.03M	-	-	-
License and Service	$9.57M	$19.70M	$34.00K	$298.00K	$3.49M
Milestone Achievement	-	$457.00K	$23.00K	$201.00K	$12.82M
Research Services	-	$2.13M	$3.06M	$4.82M	$6.37M

Sangamo Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (91.52%), License and Service (6.63%), and Service (1.86%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
License	$48.68M	$481.00K	$114.23M	$5.39M	$1.11M	$11.44M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	$547.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License and Service	-	-	$5.07M	$1.50M	$1.50M	$1.50M	$8.12M	$7.58M	$366.00K	$311.00K	$726.00K	$-1.13M	$206.00K	$227.00K	$326.00K	$321.00K	$380.00K	$-729.00K	$900.00K	$940.00K
Research Services	-	-	-	-	$554.00K	$2.06M	$2.17M	$2.03M	$1.15M	$978.00K	$640.00K	$1.13M	$613.00K	$679.00K	$987.00K	$961.00K	$1.16M	$1.72M	$1.20M	$1.81M
Milestone Achievement	-	-	-	-	-	-	-	-	$247.00K	$210.00K	$490.00K	$-759.00K	$138.00K	$154.00K	$220.00K	$216.00K	$257.00K	$-492.00K	-	-
Royalty	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Sangamo Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: License (98.89%), and Service (1.11%).

Sangamo Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ALNY	Alnylam Pharmaceuticals	$1.83B	$420.15M
SGMO	Sangamo Therapeutics	$176.23M	$356.00K
NTLA	Intellia Therapeutics	$36.27M	$9.11M
BLUE	bluebird bio	$3.60M	$16.10M
EDIT	Editas Medicine	-	-

SGMO Revenue FAQ

What is Sangamo Therapeutics’s yearly revenue?

Sangamo Therapeutics's yearly revenue for 2023 was $176.23M, representing an increase of 58.34% compared to 2022. The company's yearly revenue for 2022 was $111.3M, representing an increase of 0.54% compared to 2021. SGMO's yearly revenue for 2021 was $110.7M, representing a decrease of -6.34% compared to 2020.

What is Sangamo Therapeutics’s quarterly revenue?

Sangamo Therapeutics's quarterly revenue for Q2 2024 was $356K, a -25.99% decrease from the previous quarter (Q1 2024), and a -94.79% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $481K, a -76.44% decrease from the previous quarter (Q4 2023), and a -99.70% decrease year-over-year (Q1 2023). SGMO's quarterly revenue for Q4 2023 was $2.04M, a -78.27% decrease from the previous quarter (Q3 2023), and a -92.50% decrease year-over-year (Q4 2022).

What is Sangamo Therapeutics’s revenue growth rate?

Sangamo Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 59.20%, and for the last 5 years (2019-2023) was 72.05%.

What are Sangamo Therapeutics’s revenue streams?

Sangamo Therapeutics's revenue streams in c 23 are Service, License, and License and Service. Service generated $2.68M in revenue, accounting 1.86% of the company's total revenue License generated $132.16M in revenue, accounting 91.52% of the company's total revenue, up 256.89% year-over-year. License and Service generated $9.57M in revenue, accounting 6.63% of the company's total revenue, down -51.43% year-over-year.

What is Sangamo Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Sangamo Therapeutics was License. This segment made a revenue of $132.16M, representing 91.52% of the company's total revenue.